Latest News

We feel now is a pretty good time to analyse Oneview Healthcare PLC's ( ASX:ONE ) business as it appears the company...

Shareholders of Fujikura Ltd. ( TSE:5803 ) will be pleased this week, given that the stock price is up 19% to JP¥6,131...

Shareholders in Hanwa Co., Ltd. ( TSE:8078 ) may be thrilled to learn that the analysts have just delivered a major...

ORIX Corporation ( TSE:8591 ) shareholders are probably feeling a little disappointed, since its shares fell 2.9% to...

BOA Resources Limited ( ASX:BOA ) insiders who bought shares over the past year were rewarded handsomely last week. The...

Eli Lilly (LLY) is back in focus for investors after its recent share performance, with the stock closing at $1,127.69 and sitting within a large pharmaceutical portfolio that spans cardiometabolic, oncology, immunology, and neuroscience therapies. See our latest analysis for Eli Lilly. The recent 0.93% 1 day share price return has added to Eli Lilly’s strong momentum, with a 30 day share price return of 5.91% and a 1 year total shareholder return of 42.83%. If Eli Lilly’s run has you...

How the North Shore expansion frames Life Time Group Holdings today Life Time Group Holdings (LTH) is expanding its North Chicago presence with the opening of Life Time North Shore in Northbrook, a 114,000-square-foot club that features extensive pickleball, wellness and family-focused amenities. See our latest analysis for Life Time Group Holdings. Recent trading points to building momentum, with Life Time Group Holdings posting a 1 month share price return of 19.99%, a 3 month share price...

In June 2026, Leidos and The Modern Data Company announced a partnership to embed Modern Data’s AI-native DataOS into Leidos’ HeadWay Mission OS, creating a secure data layer that connects cloud and on‑premise systems for government agencies without requiring major system replacements. By turning fragmented agency data into secure, reusable data products built on open standards, the collaboration aims to accelerate AI adoption and shorten mission solution development cycles across Leidos’...

The sharp drop in gold prices, a stronger U.S. dollar, and rising expectations for higher Federal Reserve interest rates are reshaping where money flows in the market. While some assets like precious metals face pressure, certain U.S. bank stocks could see their core lending and deposit businesses influenced by these shifts in rates and currency. This article examines how that backdrop connects to a curated U.S. Bank Stocks screener and highlights 3 stocks that appear positively exposed to...

Earlier this week, Penguin Solutions, Inc. released an updated version of its ClusterWareAI AI Factory Platform Operating System and introduced an AI Factory Operations Agent that uses natural language queries to improve visibility, automation, and resilience across large GPU clusters. A closely timed milestone was Penguin Solutions becoming an invitation-only NVIDIA AI Factory Specialized Partner, underscoring its role in designing, deploying, and operating full‑stack NVIDIA-based AI...

Stoke Therapeutics (STOK) is drawing investor attention after recent share price moves, with the stock roughly flat over the past day but down over the past week, month and past 3 months. See our latest analysis for Stoke Therapeutics. Zooming out, the recent soft 7 day and 90 day share price returns sit alongside a 1 year total shareholder return of about 157% and a 3 year total shareholder return approaching 2x. This suggests strong long term gains despite recent cooling momentum. If you...

Shareholder Proposal Puts Linde’s Renewable Energy Use in the Spotlight NorthStar Asset Management has filed a shareholder proposal at Linde (NasdaqGS:LIN), asking for a report on the company’s renewable electricity procurement strategy ahead of the July 28, 2026 annual meeting. The request focuses on whether Linde’s board could adopt a clear policy for future renewable power purchases, adding an environmental, social, and governance angle to how some investors may already be thinking about...

Recent trading performance for Rocket Lab stock Rocket Lab (RKLB) has attracted attention after a choppy stretch in the share price, with the stock down 5.5% over the past day and 24.8% over the past week. Over the past month the stock has fallen 43.7%. However, it remains up 32.4% over the past 3 months and 123.3% over the past year, highlighting how volatile the ride has been for investors. Year to date, Rocket Lab is up 6.2%, with a market value of about US$49.4b based on the last close of...

Earlier this month, Vicor’s annual meeting confirmed an eleven-member board and endorsed executive pay, while analysts highlighted strong momentum scores and upward earnings estimate revisions supported by a recent shareholder and analyst call. At the same time, a series of scheduled insider stock option exercises and sales, alongside fresh option grants to senior executives, contrasts with generally positive analyst sentiment and suggests investors are weighing governance, incentives, and...

Hub Group (HUBG) is back in focus as investors look ahead to Friday’s earnings release, after the logistics provider last quarter exceeded revenue expectations but still reported a year-on-year decline and faces similar expectations again. See our latest analysis for Hub Group. At a latest share price of $43.90, Hub Group has seen a 24.08% 90 day share price return and a 32.08% total shareholder return over the past year, which points to building momentum ahead of Friday’s earnings update. If...

Coles Group (ASX:COL) is back in the spotlight as new supermarket excessive pricing rules approach, with investors weighing its defensive sales profile, digital investments and ongoing cost pressures in the broader consumer sector. See our latest analysis for Coles Group. Recent price action suggests momentum in Coles Group shares is building, with a 30 day share price return of 14.28% and year to date share price return of 14.39%. The 5 year total shareholder return of 74.92% reflects how...

Curious whether Spotify Technology is priced fairly today or if the recent volatility has created an opportunity? This article focuses squarely on what the current share price might mean for value conscious investors. At a last close of US$441.21, the stock is down 5.7% over the past week, 16.7% over the past month and 23.3% year to date, although it is still up 177.0% over three years and 64.2% over five years. Recent coverage around Spotify Technology has centered on its role in the...

In the past week, PulteGroup has drawn heightened investor attention ahead of its expected 22 July 2026 earnings release, with analysts projecting year-over-year declines in earnings per share and revenue and assigning the stock a mixed Hold/Sell ranking. At the same time, a new PulteGroup survey highlights that over half of move-up buyers are choosing homes the same size or smaller, emphasizing layout, design, and lifestyle fit over raw square footage. With analysts bracing for softer...

BioNTech (NasdaqGS:BNTX) shares have recently drawn investor attention after a period marked by mixed returns, including a gain of about 5% over the past 3 months but a decline of roughly 15% over the past year. See our latest analysis for BioNTech. At the current share price of US$90.00, BioNTech’s recent trading has been fairly muted, with the 30 day share price return down 2.44% and the 90 day share price return up 5.04%, while the 5 year total shareholder return is down 59.43%. This...

Recently, Atlassian was named a Leader in Gartner’s inaugural Magic Quadrant for Developer Productivity Insight Platforms, reflecting strong execution and vision among 12 vendors and coinciding with Q3 FY2026 revenue growth of 32% year over year and cloud revenue growth of 29%. The combination of this third-party validation and the Service Collection surpassing US$1.00 billion in annual recurring revenue underscores Atlassian’s push to become a broader workflow and AI-assisted productivity...

Abbott Laboratories (NYSE:ABT) is rolling out its Instinct continuous glucose monitoring sensor across Europe as part of MiniMed insulin pump systems. The integration brings Abbott's CGM technology directly into new automated insulin delivery platforms for diabetes patients. At the same time, Abbott is increasing its presence in emerging markets through biosimilar and branded generic medicine launches and regulatory approvals. For investors watching Abbott Laboratories, these moves connect...

Bendigo and Adelaide Bank recently reported a 2.8% lift in cash earnings to A$256.4 million for the half-year to December 2025, maintained a fully franked 30 cent interim dividend, and updated investors on its multi‑year transformation program. The bank’s push to streamline costs, consolidate core systems and scale its digital bank Up, now serving over one million customers, alongside absorbing Rural Bank into its agribusiness arm is reshaping how it competes in retail and rural...

T-Mobile US has recently declared a cash dividend of US$1.02 per share payable on September 10, 2026, while also expanding its global footprint with a new capability center in Hyderabad, India and securing fresh mid-band spectrum licenses in a recent FCC auction. Together with a new multi-year 5G partnership with the USGA and ongoing community investment through its Hometown Grants program, these moves highlight how T-Mobile is pairing network expansion with brand-building and...

Earlier this week, Simply Good Foods reported a softer quarter, with year-on-year revenue falling short of analyst expectations and full-year EBITDA and next-quarter revenue guidance coming in lower than anticipated. Within the shelf-stable food group, Simply Good Foods’ results stood out as the weakest versus analyst forecasts, highlighting company-specific execution and outlook challenges rather than purely sector-wide pressure. We’ll now examine how weaker revenue trends and reduced...